Background -Although posterior subcapsular cataract complicates both systemic and topical corticosteroid therapy, the literature on the effects of inhaled corticosteroids is conflicting. Methods -One hundred and forty children and young adults on inhaled corticosteroids were examined by slit lamp ophthalmoscopy after pupillary dilatation; 103 had received one or more short courses (< 7 days) of oral corticosteroids in the management of acute asthmatic attacks and four had also received one or more prolonged courses (l> 4 weeks) of alternate day oral corticosteroid therapy. Results -Bilateral posterior subcapsular cataract was identified in one girl who had received several prolonged courses of oral corticosteroids, but was not identified in any other patient.
Conclusions -There is no evidence to support the contention that inhaled corticosteroid therapy on its own, or in association with short courses of oral corticosteroid therapy, might cause cataracts. Although children receiving long term systemic corticosteroid therapy should be screened for cataracts, this is unnecessary in children on inhaled corticosteroids alone. The association between systemic corticosteroid therapy and the development of posterior subcapsular cataract, first described by Black et al in adults in 1960,' has also been reported in children receiving systemic corticosteroids for asthma. There are also reports Posterior subcapsular cataract and inhaled corticosteroid therapy Although most patients had received the same drug since treatment was started, some had had both beclomethasone and budesonide at different times and these are shown separately. Bilateral posterior subcapsular cataracts were identified in one patient who had received frequent courses, both short and long, of oral prednisolone; her history is presented in detail below. No other cataract was found in any other patient in this study.
CASE REPORT
The patient was 13 years old at the time of ophthalmic examination. Her father had asthma and her maternal grandfather had agerelated cataracts. There was no other family history of note. She had suffered from asthma since the age of two and, from the age of six, the severity of her asthma had gradually increased. She was treated with a wide variety of medications which included sodium cromoglycate, I agonists (including inhaled salmeterol and controlled release oral salbutamol), ipratropium bromide, sustained release oral theophylline, inhaled budesonide and beclomethasone through various inhalation devices, oral prednisolone and, because of psychological disturbance in relation to prednisolone therapy, betamethasone. She had required frequent admission to hospital for exacerbations of asthma, invariably receiving oral steroids, and numerous other exacerbations had been dealt with by her general practitioner using nebulised 32 agonists, short courses of oral corticosteroids being required about four times a year. In May 1992 she was started on oral prednisolone 20 mg on alternate days and, at the time of the examination five months later, she was still on prednisolone 15 mg on alternate days and budesonide 600 jig twice daily, as well as various bronchodilator inhalers and nebuliser solutions.
Discussion
Inhaled corticosteroid therapy is recommended for the prophylaxis of asthma in those children in whom treatment with cromoglycate has failed.4 However, despite the efficacy of inhaled corticosteroids, oral corticosteroids must still be used in the management of severe acute asthma4 and occasionally long term oral therapy has to be prescribed for problematic cases. It is therefore difficult to identify a substantial number of children whose corticosteroid therapy has been given exclusively by the inhaled route with the result that, whereas the association between posterior subcapsular cataract formation and prolonged systemic corticosteroid therapy has been well documented in asthmatic adults5 and children,67 the relationship with inhaled corticosteroids is much less clear.
Various dose-related systemic side effects have been observed with inhaled corticosteroids' and it would not be surprising if such therapy were also associated with posterior subcapsular cataract formation. However, despite the use of relatively high doses of inhaled corticosteroids in the present series, and the exposure ofthe majority of our patients to short courses of oral corticosteroid therapy for acute attacks, we found posterior subcapsular cataract only in association with the prolonged administration of oral corticosteroids. There were no apparent differences between the child with posterior subcapsular cataract and the other children on long term oral corticosteroids to explain why she developed cataract; cases 1 and 3 had had similar cumulative doses of inhaled corticosteroids and more prolonged treatment with alternate day oral corticosteroids, supporting the proposal that there is a personal predisposition to cataractogenesis,9 possibly based on a genetic factor.'0 Taking the findings of the present study in conjunction with those of Simons et al2 and Tinkelman et al,3 the failure to identify posterior subcapsular cataract in a total of 333 (136 + 95+ 102) patients on inhaled corticosteroids implies that the risk of developing this complication is extremely low, and we agree with Simons et a!2 in concluding that the routine ophthalmological screening of patients on inhaled corticosteroids is not warranted on present evidence.
